James W. Raitt, MD Professor of Medicine Chief, Division of Immunology and Rheumatology Stanford University Dr. Robinson leads a translational immunology laboratory focused on elucidating the role of Epstein–Barr virus (EBV) and other microbial drivers in the pathogenesis of autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS). His laboratory pioneered the development of high-density protein arrays and advanced high-throughput sequencing technologies to directly identify EBV-infected B cells, define antibody specificities, and dissect mechanisms of immune dysregulation. Using these platforms, his group demonstrated that EBV directly infects and transcriptionally reprograms autoreactive B cells into pathogenic antigen-presenting cells that initiate and amplify autoreactive T- and B-cell responses driving the pathogenesis of SLE and MS. Dr. Robinson co-founded the Stanford Human Immune Monitoring Center and has served in numerous national leadership roles in immunology. He currently serves as Treasurer and a member of the Board of Directors of the Federation of Clinical Immunology Societies and sits on the editorial boards of multiple journals. An inventor on 23 patent applications, technologies developed in his Stanford and VA laboratories have been licensed to nine biotechnology companies. He was elected to the American Society for Clinical Investigation (ASCI), the Henry Kunkel Society, and the Association of American Physicians (AAP). Dr. Robinson received his MD and PhD degrees from Stanford University and completed his residency training in internal medicine at the University of California, San Francisco.